MD Anderson Robotic Gastrectomy Course

---

Saturday, March 5, 2022, 7:00 AM - 4:00 PM, Memorial Hermann SIRI Lab


AMA PRA Category 1 Credits™ (0.00 hours)

On the day of the course geared to, General Surgeons, Surgical Oncologists and Surgical Trainees who are willing to expand practice to include oncologic robotic gastrectomy and D2 lymph node dissection; we will start with didactic lectures of topics covering from evidence-based D2 lymph node dissection to step-by-step robotic gastrectomy techniques provided by esteemed international faculty members. Then we will hold a surgical cadaver labs for participating surgeons, using up-to-date Intuitive Surgical DaVinci Robotic Surgical Platform (Xi system). We expect that each participating surgeon will have abundant hands-on console time during this course, by limiting number of participants (maximum three for each cadaver/robotic surgical system).  

In addition to being the FIRST robotic gastrectomy program to be held in the United States, this will be the first robotic gastrectomy program to use peer-based coaching to facilitate learning and improve collaboration amongst international surgeons. We hope you will join us in this exciting program with our overall goal to improve gastric cancer care, globally.

1. Learn anatomy, definition, and evidence of D2 lymph node dissection for gastric cancer;
2. Learn effective tricks to overcome challenges during robotic gastrectomy;
3. Gain skills to perform robotic total and distal gastrectomy, and various reconstruction techniques.

Please be advised that currently we are at capacity, if you would like to be put on the Wait List.  Please email [email protected] 

MD Anderson Robotic Gastrectomy Course for Gastric Cancer

On behalf of the Division of Surgical Oncology and The University of Texas MD Anderson Cancer Center, Houston, Texas, we invite you to participate in a surgical skills program for the Robotic Gastrectomy Course on Saturday, March 5th, 2022, immediately preceding International Gastric Cancer Congress 2022. We hope to learn from each other up-to-date robotic gastrectomy techniques, and evidence behind them, for gastric cancer patients in Houston, Texas.

The MD Anderson Robotic Gastrectomy Course - IGCC 2022 will take place at the Memorial Hermann SIRI lab located at 10905 Memorial Hermann Drive, Suite 118, Pearland, Texas. 

Activity Director: Naruhiko Ikoma, MD, MD Anderson Cancer Center
Activity Co-Director: Brian Badgwell, MD, MD Anderson Cancer Center

Guest Faculty 
   Hyoung-Il Kim, MD, Yonsei University College of Medicine
   Takahiro Kinoshita, MD, National Cancer Center East
   Richard van Hillegersberg, MD, UMC Utrecht

Program 

7:00 am   - Registration Check-In / Breakfast
7:30 am   - Lectures
9:30 am   - Hands-on Distal Gastrectomy Cadaver Course
12:00 pm - Lunch
12:30 pm - Hands-on Total Gastrectomy Cadaver Course 
3:00 pm   - Closing Remarks

Note: Step-by-Step Robotic Gastrectomy videos will be provided for attendees preparation prior to the course.

COVID-19 Restrictions/Policies - Be prepared to follow MD Anderson's current Covid protocol.

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

COURSE REGISTRATION FEES

General Registration Rate $500.00

We accept the following forms of payment:
• Credit Cards (MasterCard, VISA, and American Express)
• Check (payable through U.S. banks only)
• Mail to:
           Continuing Professional Education – Unit 178
           The University of Texas MD Anderson Cancer Center
           P.O. Box 301407 Houston, Texas 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

Telephone registrations are not accepted.

The Department of Continuing Professional Education reserves the right to cancel activities prior to the scheduled date if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, email or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the Department of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee. 

The Department of Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, please contact Continuing Professional Education at 713-792- 2223 or toll free at 866-849-5866.

 

The organizing committee thanks you in advance for your participation in this robotic gastrectomy course, as well as the IGCC 2022. We do know that as COVID and its various variants continue to cycle through our communities, many of you may have questions about whether the meeting will take place as scheduled. While we are optimistic that we will see you in Houston, we will continue to carefully monitor the situation and see how things stand in mid-February.

Understanding that the situation may be different by regions, and accept free-cancellation policy until 14 days prior to the event. If you are on waiting list, we will notify as soon as the spot available for you.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.